Absorption |
Blood-Brain Barrier | BBB- | 0.6854 |
Human Intestinal Absorption | HIA+ | 0.9596 |
Caco-2 Permeability | Caco2- | 0.5164 |
P-glycoprotein Substrate | Substrate | 0.7463 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8026 |
Non-inhibitor | 0.5135 |
Renal Organic Cation Transporter | Non-inhibitor | 0.5359 |
Distribution |
Subcellular localization | Mitochondria | 0.8299 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8070 |
CYP450 2D6 Substrate | Non-substrate | 0.6413 |
CYP450 3A4 Substrate | Non-substrate | 0.6680 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8077 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9056 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5560 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9173 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7120 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9010 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.5868 |
Inhibitor | 0.8482 |
AMES Toxicity | Non AMES toxic | 0.5657 |
Carcinogens | Non-carcinogens | 0.8947 |
Fish Toxicity | High FHMT | 0.8990 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9248 |
Honey Bee Toxicity | Low HBT | 0.6793 |
Biodegradation | Not ready biodegradable | 0.7510 |
Acute Oral Toxicity | III | 0.6787 |
Carcinogenicity (Three-class) | Non-required | 0.7093 |